Value of Ultrasound-Guided Microwave Ablation for Breast Fibroadenoma

Starting soon · Not applicable

Conditions studied: Breast Fibroadenoma

In brief

assess the efficacy of MWA in reducing fibroadenoma volume and achieving complete lesion regression at 12 months post-treatment

Key facts

Study ID

NCT07719634

Run by

Assiut University

People needed

45

Starts

2026-08-01

Expected to finish

2028-08-01

Last updated by the study team

2026-07-22

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female participants ≥ 18 years
• Diagnosed with fibroadenoma by clinical and ultrasonographic signs, core needle biopsy done only if atypical fibroadenoma.
• Lesion(s) measurable by ultrasound (e.g., diameter 0.7 - 3.0 cm),distance from breast lesion to the skin and pectoralis muscle exceeding 10 mm and the lesion away from nipple areola area .
• Symptomatic lesion or patient preference for minimally invasive treatment

You may not qualify if…

• Malignancy or high suspicion of malignancy, BIRADs 4 or more/if pathological proved.
• Active infection.
• Coagulopathy or contraindications to ablation.
• Distance from breast lesion to the skin and pectoralis muscle less than 10 mm and the lesion near nipple areola area .

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.